Skip to main content
Medical information Clinical review pending

Gynecological Testing

Abortion Panel Anti-HLA Antibodies Test

The Abortion Panel Anti-HLA Antibodies Test helps identify potential immunological factors contributing to recurrent pregnancy loss. This test is recommended for women experiencing multiple miscarriages.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
2 mL (1 mL min.) serum from 1 SST tube, 6 mL (4 mL min.) whole blood in 2 Lavender Top (EDTA) tubes, 3 mL (2 mL min.) whole blood in 1 Green Top (Sodium Heparin) tube.
Results
Approximately 1 week. Confirm with the laboratory before booking.
Preparation
No specific patient preparation is required. Confirm with the laboratory before booking.
Test priceKSh 44,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Abortion Panel Anti-HLA Antibodies Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓History of two or more consecutive miscarriages
  • ✓Recurrent pregnancy loss
  • ✓Investigation of potential immunological causes for pregnancy loss
  • ✓Women with autoimmune disorders experiencing pregnancy loss
  • ✓Family history of reproductive issues
02

In plain language

What this test helps you understand

This test helps identify potential immunological factors, such as anti-HLA antibodies, that may be associated with recurrent pregnancy loss, aiding in the investigation of causes for multiple miscarriages.
The Abortion Panel Anti-HLA Antibodies Test is a specialized diagnostic tool designed to assist women facing recurrent pregnancy loss. This test identifies the presence of anti-HLA antibodies, which can potentially interfere with successful implantation and the growth of the fetus. Understanding these factors is crucial for women who have experienced multiple miscarriages, as it aids in tailoring future pregnancy management strategies.

This test measures specific antibodies in the blood that may be associated with recurrent abortions. The components evaluated include CD3, CD19, CD16 + CD56, and TNF-alpha. These markers help in understanding the immune response and its potential role in pregnancy loss.

Women who have experienced two or more consecutive miscarriages or those with a history of recurrent abortions should consider this test. Risk factors may include previous pregnancy losses, autoimmune disorders, or a family history of reproductive issues. If you exhibit any of these symptoms, consulting a healthcare professional about this test is advisable.

Taking the Abortion Panel Anti-HLA Antibodies Test offers several benefits, including identifying potential immunological causes of recurrent miscarriages, guiding treatment options to improve future pregnancy outcomes, and providing clarity for expecting mothers. Understanding your body's immune response can play a significant role in achieving a successful pregnancy.

Results from the Abortion Panel Anti-HLA Antibodies Test will indicate the presence or absence of specific antibodies. A healthcare provider will interpret these results and discuss their implications for your reproductive health. It is essential to follow up with your gynecologist to understand the next steps based on your results.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo specific patient preparation is required. Confirm with the laboratory before booking.
Sample2 mL (1 mL min.) serum from 1 SST tube, 6 mL (4 mL min.) whole blood in 2 Lavender Top (EDTA) tubes, 3 mL (2 mL min.) whole blood in 1 Green Top (Sodium Heparin) tube.
MethodologyConfirm with the laboratory before booking.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test identifies specific antibodies but does not definitively diagnose the cause of pregnancy loss. Results must be interpreted by a qualified healthcare professional in conjunction with clinical findings. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

This test looks for specific antibodies in your blood that might be linked to repeated miscarriages, helping to understand potential immune system involvement.
Women who have experienced two or more consecutive miscarriages, or those with a history of recurrent pregnancy loss, may be advised to consider this test.
The test measures levels of specific antibodies like CD3, CD19, CD16 + CD56, and TNF-alpha, which are markers related to immune responses.
A healthcare provider will interpret the results based on your individual medical history and clinical situation. Discuss the results with your doctor.
The test requires serum and whole blood samples collected in specific types of tubes (SST, Lavender Top, Green Top).
Results are typically available within approximately 1 week, but this can vary. Confirm the exact turnaround time with the laboratory.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp